Literature DB >> 10765089

Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma.

N Lightfoot1, M Conlon, N Kreiger, R Bissett, M Desai, P Warde, H M Prichard.   

Abstract

OBJECTIVE: To determine the impact of non-invasive imaging, specifically ultrasound imaging and computed tomography, on the incidental detection of renal cell carcinoma during two consecutive time periods, one prior and one subsequent to the acquisition of imaging equipment.
METHODS: All located patient charts (83% of 207) of renal cell carcinoma cases (n = 172) were reviewed, and categorized by presentation method as 'incidental' or 'nonincidental' cases, based on defined criteria. Clinical information was recorded, cases were staged, and survival estimates were calculated.
RESULTS: More than a third of the 172 cases were categorized as incidentally detected, most of which (82.5%) were detected during the latter time period. Either ultrasound or CT imaging was credited with detecting over 80% of the incidentally detected tumors.
CONCLUSION: Ultrasound and CT imaging have contributed to the incidental detection of renal cell carcinomas during the two time periods. Stage significantly predicted survival (p<0.001) in a Cox proportional hazard model that also controlled for presentation, sex, and age.

Entities:  

Mesh:

Year:  2000        PMID: 10765089     DOI: 10.1159/000020188

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  27 in total

Review 1.  [Radical and partial nephrectomy for RCC: laparoscopy or open surgery].

Authors:  G Janetschek
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

2.  Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.

Authors:  Marki E Klapperich; E Jason Abel; Timothy J Ziemlewicz; Sara Best; Meghan G Lubner; Stephen Y Nakada; J Louis Hinshaw; Christopher L Brace; Fred T Lee; Shane A Wells
Journal:  Radiology       Date:  2017-01-11       Impact factor: 11.105

Review 3.  Update on cryoablation for treatment of small renal mass: oncologic control, renal function preservation, and rate of complications.

Authors:  Anil Kapoor; Yuding Wang; Brad Dishan; Stephen E Pautler
Journal:  Curr Urol Rep       Date:  2014-04       Impact factor: 3.092

Review 4.  Early renal cell cancer.

Authors:  Yoshihiko Tomita
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

5.  Identification of the primary tumour with the help of diffusion-weighted MRI in a patient with autosomal dominant polycystic kidney disease and metastatic renal cell carcinoma.

Authors:  M Zeile; D Andreou; A Poellinger; P U Tunn; O Dudeck
Journal:  Br J Radiol       Date:  2011-07       Impact factor: 3.039

6.  Two cases of pseudoaneurysm of the renal artery following laparoscopic partial nephrectomy for renal cell carcinoma: CT angiographic evaluation.

Authors:  Carolyn J Moore; Shai M Rozen; Elliot K Fishman
Journal:  Emerg Radiol       Date:  2003-11-29

Review 7.  Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible?

Authors:  R Autorino; G Di Lorenzo; R Damiano; S Perdonà; A Oliva; M D'Armiento; M De Sio
Journal:  World J Urol       Date:  2003-07-12       Impact factor: 4.226

8.  Clinical symptoms related to renal cell carcinoma are independent prognostic factors for intraoperative complications and overall survival.

Authors:  Attila Szendroi; Adám Tabák; Peter Riesz; Miklós Szucs; Peter Nyírády; Attila Majoros; Gabriel Haas; Imre Romics
Journal:  Int Urol Nephrol       Date:  2009-03-13       Impact factor: 2.370

9.  The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma.

Authors:  Tim J van Oostenbrugge; Stephanie G C Kroeze; J L H Ruud Bosch; Harm H E van Melick
Journal:  World J Urol       Date:  2014-09-02       Impact factor: 4.226

Review 10.  The Role of DNA Methylation in Renal Cell Carcinoma.

Authors:  Brittany N Lasseigne; James D Brooks
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.